# AptaPharma Inc. – FDA Inspection, Sep 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/aptapharma-inc/412628c1-3ed7-4ab7-afc9-0f5453b9d583
Source feed: FDA_Inspections

> FDA inspection 1102699 of AptaPharma Inc., September 25, 2019. Classification: No Action Indicated (NAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102699
- Company Name: AptaPharma Inc.
- Inspection Date: 2019-09-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1331256 - 2026-08-14](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/5a27f40e-6ca9-448c-a9e6-9ab663ccfcec)
- FDA Inspection 1231140 - 2024-10-24
- [FDA Inspection 1205203 - 2023-05-15](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/acbc1cae-f7f4-45ce-a9dd-baac18f57175)
- [FDA Inspection 1045668 - 2018-03-16](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/56b08717-7de1-4c2d-9b87-592490ed7578)
- FDA Inspection 884304 - 2014-06-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nancy-m-espinal/f4494790-6a37-4998-853c-f859a0eb3330)

Company: https://www.keypedia.com/companies/aptapharma-inc/8390ea00-697d-4f5d-9e50-407830a6b2ee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
